Attached files
| file | filename |
|---|---|
| EX-23 - EX-23 - BIOCRYST PHARMACEUTICALS INC | g26459exv23.htm |
| EX-31.2 - EX-31.2 - BIOCRYST PHARMACEUTICALS INC | g26459exv31w2.htm |
| EX-32.2 - EX-32.2 - BIOCRYST PHARMACEUTICALS INC | g26459exv32w2.htm |
| EX-31.1 - EX-31.1 - BIOCRYST PHARMACEUTICALS INC | g26459exv31w1.htm |
| EX-10.12 - EX-10.12 - BIOCRYST PHARMACEUTICALS INC | g26459exv10w12.htm |
| EX-10.25 - EX-10.25 - BIOCRYST PHARMACEUTICALS INC | g26459exv10w25.htm |
| 10-K - FORM 10-K - BIOCRYST PHARMACEUTICALS INC | g26459e10vk.htm |
Exhibit 32.1
CERTIFICATION
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of BioCryst
Pharmaceuticals, Inc. (the “Company”) on
Form 10-K
for the period ending December 31, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the
“Report”), I, Jon P. Stonehouse, Chief Executive
Officer of the Company, certify, pursuant to 18 U.S.C.
§ 1350, as adopted pursuant to § 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1) The Report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
(2) The information contained in the Report fairly
presents, in all material respects, the financial condition and
results of operations of the Company.
/s/ Jon
P. Stonehouse
Jon P. Stonehouse
Chief Executive Officer
March 15, 2011
This certification is furnished with this Report on
Form 10-K
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
and shall not, except to the extent required by such Act, be
deemed filed by the Company for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the
“Exchange Act”). Such certification will not be deemed
to be incorporated by reference into any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except
to the extent that the Company specifically incorporates it by
reference.